PDLIM7 and neoplasm: In a preventive protocol (protocol #1), antibodies against LMP1 (S12) were administered as five intraperitoneal injections of 25 μg at 5-day intervals, finishing three days before tumor growth, or as five consecutive daily injections beginning either simultaneously with tumor development (protocol #2) or on day 8 when the tumors had reached a diameter of approximately 8 mm (c666-1) or 12–15 mm (AGS) (protocol #3).